Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 01)
Selexipag Titration Pack Kit
Product Images NDC 70771-1801
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Selexipag Titration Pack (NDC 70771-1801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 02)
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 03)
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 04)
This text provides information on the Kaplan-Meier analysis for patients event-free percentage, hazard ratio, and statistical significance. The hazard ratio of 0.60 suggests a lower risk in the treatment group compared to the placebo group. The p-value being less than 0.0001 indicates a statistically significant difference between the treatment and placebo groups. The data also includes the number of patients at risk over time for both the Selexipag and placebo groups.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 05)
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 06)
This text provides a comparison between Selexipag and Placebo patients at different time points measured in months from randomization. It includes the number of patients at risk at each time point for both groups.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 07)
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 08)
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 09)
This text provides details about Selexipag tablets, each containing 200 mcg of selexpag. It includes information on dosage, storage conditions, manufacturer, and a reminder to keep drugs out of reach of children. The text also mentions a coding template and the specific size of the tablets.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 10)
This text provides information about a medication called Selexipag. It contains 400 mcg tablets and includes important details such as dosage, storage instructions, and manufacturer (Zydus). The package is child-resistant and patients are advised to keep the tablets away from children. The NDC code for the medication is 70771-1794-6.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 11)
This is a description of a Gver Coding Template. It contains 60 tablets, each coated and containing 600 mcg of a substance. The package includes information about dosage, storage conditions, child-resistant packaging, and a reminder to keep all drugs out of the reach of children. The manufacturer is identified as 2yd@ Gl.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 12)
This text is a product label for Gver Coding Template tablets. Each film-coated tablet contains 800 mcg of selexipag. It is advised to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The package is child-resistant and contains 60 tablets. The usual dosage information can be found in the package insert. The label also includes a warning to keep all drugs out of the reach of children.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 13)
This is a description for a medication package labeled with 60 tablets of 1000mg each. The medication is in the form of coated tablets with prescribing information included. It is advised to store the medication at a temperature between 20°C to 25°C (68°F to 77°F), and to keep it out of reach of children as the package is child-resistant.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 14)
This text describes a packaging label for Selexipag tablets, containing 60 tablets with a dosage of 1200 mcg per tablet. It provides instructions to read the prescribing information before use, store at a controlled room temperature, ensure child-resistant packaging, and keep all drugs out of reach of children. The tablets are manufactured by Zydus Lifesciences Ltd. in India.*
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 15)
This text is a label for Gver Coding Template containing Selexipag tablets. The label includes dosage instructions, storage conditions, and precautions for child safety. Each film-coated tablet contains Selexipag. The package contains 60 tablets and must be stored at a temperature between 20°C to 25°C. Additionally, it emphasizes keeping the package and all drugs out of the reach of children. *
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 16)
Image (2eab2a03 A903 483f A6bc 606bc0d3d0ab 17)
This text appears to be a description of a medication product - Selexipag Tablets. The tablets are available in two strengths: 200 mcg and 800 mcg. The packaging includes 140 tablets for the 200 mcg strength and 60 tablets for the 800 mcg strength. It is recommended to read the prescribing information before use and store the tablets at a temperature between 20°C to 25°C. The manufacturer is mentioned as Zydus Lifesciences Ltd. from Ahmedabad, India. Additionally, the text provides details on the National Drug Code (NDC) for the product and emphasizes keeping the medication out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
